Navigation Links
Mammograms Can Measure How Breast Cancer Drug Is Working: Study
Date:4/23/2013

MONDAY, April 22 (HealthDay News) -- Mammograms can be used to see how well breast cancer patients are responding to treatment with the drug tamoxifen, a new study suggests.

Researchers at the Karolinska Institute in Sweden report that women who saw a 20 percent or more reduction in breast density during tamoxifen treatment had a 50 percent lower risk of dying from breast cancer over an average of 15 years, compared with women who had little or no change in breast tissue density during treatment.

The study uncovered a link between reductions in breast density while on tamoxifen and a lowered risk of death. However, it didn't find a cause-and-effect relationship.

Using mammograms to determine if a patient is responding to tamoxifen can be done at an early stage of treatment, the researchers added.

The Swedish team looked at nearly 1,000 postmenopausal women who had been treated for breast cancer. About half of them had been treated with tamoxifen, according to the study, which was published online April 22 in the Journal of Clinical Oncology.

Tamoxifen is a common hormone-therapy drug typically given over five years to prevent relapse in women who have completed their primary breast cancer treatment. However, there has been no way to assess which patients are most likely to respond to tamoxifen treatment.

These findings suggest a possible method for doing so, the researchers said.

"What's needed is accurate measurement of mammographic density, which isn't currently routine," Per Hall, a professor in the department of medical epidemiology and biostatistics, said in a Karolinska Institute news release. "Measuring changes in density can be a simple and cheap means of assessing the effect of the treatment. If a patient is not responding to tamoxifen, maybe they should be given a different drug."

More information

The U.S. National Cancer Institute has more about breast cancer treatment.

-- Robert Preidt

SOURCE: Karolinska Institute, news release, April 22, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Routine mammograms may result in significant overdiagnosis of invasive breast cancer
2. Here Are the Women Who Need Mammograms in Their 40s: Study
3. No family history not a good reason for women 40-49 to stop yearly screening mammograms
4. Mammograms Beat Thermography for Breast Cancer Detection: Study
5. US mammograms decline after task force recommendation, Mayo Clinic finds
6. Mammograms Have Limited or No Effect on Breast Cancer Deaths: Study
7. Breast Cancer Charity Overstates Value of Mammograms: Researchers
8. Mammograms Do Not Prevent Advanced Breast Cancer, Study Suggests
9. For Older Women, Mammograms Every 2 Years Found as Good as Annual Test
10. Mammograms Every Other Year OK for Women Over 50: Study
11. False-Positive Mammograms Can Trigger Long-Term Distress
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mammograms Can Measure How Breast Cancer Drug Is Working: Study
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: